Observational study identifies associations between maternal omega-3 levels and preterm birth risk, suggesting potential pathways for intervention.
Background: Maternal omega-3 status is measurable through red blood cell fatty acid analysis; however, current laboratory thresholds are mostly derived from DHA supplementation trials rather than real-world pathology datasets, leaving uncertainty around baseline risk patterns. Clarifying how omega-3 categories relate to gestational age (GA) may support improved preterm birth (PTB) risk identification. 1-3
No takes yet. Share an insight, caveat, or question.
Antonovich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: